Clinical Trials Directory

Trials / Completed

CompletedNCT02574351

Study of T-Regulatory Cells in Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To study whether the immune response as directed by regulatory T cells is different between obese asthmatics, normal weight asthmatics and healthy controls.

Detailed description

The investigators hypothesize that the increase in asthma severity in obese patients is, at least in part, related to a defective number or function of regulatory T cells (Tregs). That is in the obese asthmatic subject a defective Treg profile would augment the inflammation of asthma (a synergistic effect). Alternatively, that Treg dysfunction in obesity might affect asthma independently (an additive effect). To test these hypotheses, the investigators plan to conduct an observational controlled study to compare Treg profile in obese and normal-weight individuals with and without asthma. This is an exploratory study to investigate the following: 1. To determine whether Treg number and function differs between obese and normal-weight individuals with and without asthma. 2. To determine whether serum leptin levels differ between obese and normal-weight individuals with and without asthma.

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood draw, breathing testA blood draw,breathing test will be performed on every participant

Timeline

Start date
2011-05-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-10-12
Last updated
2016-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02574351. Inclusion in this directory is not an endorsement.